| Name | Title | Contact Details |
|---|
EPOCH offers a 401(k) Retirement Savings Plan, with a variety of 25 fund options ranging from low to high risk, to choose from.
Apria Healthcare is one of the nation`s leading providers of home respiratory services and certain medical equipment, including oxygen therapy, inhalation therapies, sleep apnea treatment, and negative pressure wound therapy. Apria was the first such company to obtain voluntary accreditation from the Joint Commission and has been continuously accredited for more than 25 consecutive years. Apria operates more than 290 service locations throughout the United States and serves more than 2 million patients each year. In many cases, it`s a new beginning for its patients with the chance to return home from the hospital to resume their lives. What makes Apria industry leading is its focus on the patient as well as its employees. The people who work at Apria have passion and a commitment to excellence and we foster that compassion. Apria employees continually enhance their skills, receive training, and exhibit the kind of professionalism that makes Apria a highly effective and knowledgeable resource for our patients and healthcare customers.
Park Dental Research Corp is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).
Quality Medical Evaluations is a Westborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.